CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −17,772 | $2.31 | $41K | 1,393,771 |
| 2024-03-04 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −14,964 | $2.10 | $31K | 1,411,543 |
| 2024-03-01 | Desai Neil EXECUTIVE CHAIRMAN | Sale | −27,036 | $1.97 | $53K | 1,426,507 |
| 2024-03-01 | ITRI LORETTTA M CHIEF MEDICAL OFFICER | Grant or award · Stock option (right to buy) | +76,813 | 76,813 | ||
| 2024-03-01 | ITRI LORETTTA M CHIEF MEDICAL OFFICER | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-01 | ITRI LORETTTA M CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2024-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Stock option (right to buy) | +30,768 | 30,768 | ||
| 2024-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2024-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +65,000 | 65,000 | ||
| 2024-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +138,263 | 138,263 | ||
| 2024-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2024-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +27,000 | 27,000 | ||
| 2024-02-01 | Desai Neil Executive Chairman | Sale 10b5-1 | −42,000 | $1.74 | $73K | 1,453,543 |
| 2024-01-02 | Desai Neil Executive Chairman | Sale | −42,000 | $2.06 | $87K | 1,495,543 |
| 2023-12-06 | Desai Neil Executive Chairman | Sale | −7,037 | $4.82 | $34K | 1,537,543 |
| 2023-12-05 | Desai Neil Executive Chairman | Sale | −15,740 | $5.02 | $79K | 1,544,580 |
| 2023-12-04 | Desai Neil Executive Chairman | Sale | −10,876 | $5.15 | $56K | 1,560,320 |
| 2023-12-01 | Desai Neil Executive Chairman | Sale | −8,347 | $5.14 | $43K | 1,571,196 |
| 2023-11-02 | Desai Neil Executive Chairman | Sale | −31,662 | $4.46 | $141K | 1,579,543 |
| 2023-11-01 | Desai Neil Executive Chairman | Sale | −10,338 | $4.32 | $45K | 1,611,205 |
Page 7 of 9 · 171 trades